4//SEC Filing
EW HEALTHCARE PARTNERS FUND 2-A, L.P. 4
Accession 0000950170-24-016357
CIK 0001561921other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 4:10 PM ET
Size
68.5 KB
Accession
0000950170-24-016357
Insider Transaction Report
Form 4
TELA Bio, Inc.TELA
EW HEALTHCARE PARTNERS FUND 2, L.P.
10% OwnerOther
Transactions
- Purchase
Common Stock, par value $0.001 per share
2020-04-02$8.01/sh+15,000$120,150→ 1,184,231 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-08-03$11.86/sh+1,400$16,604→ 1,454,993 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-22$9.14/sh+10,000$91,400→ 1,371,768 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-08-11$12.95/sh+821$10,632→ 1,466,014 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-07-30$12.22/sh+7,400$90,428→ 1,421,768 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-08-14$12.95/sh+9,179$118,868→ 1,475,193 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2022-07-14$8.01/sh+5,000$40,050→ 3,610,709 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-06$8.10/sh+17,866$144,715→ 1,211,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-09$8.47/sh+25,000$211,750→ 1,271,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-13$7.96/sh+10,000$79,600→ 1,281,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-07-28$12.48/sh+10,000$124,800→ 1,401,768 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-03$8.01/sh+9,634$77,168→ 1,193,865 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-01$7.47/sh+15,000$112,050→ 1,169,231 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-07$8.20/sh+20,000$164,000→ 1,231,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-08$8.37/sh+15,000$125,550→ 1,246,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-14$8.07/sh+15,000$121,050→ 1,296,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-21$8.32/sh+3,037$25,268→ 1,361,768 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-07-29$12.39/sh+12,600$156,114→ 1,414,368 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-08-28$12.85/sh+100$1,285→ 1,475,293 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-16$8.00/sh+17,500$140,000→ 1,326,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-17$8.25/sh+25,000$206,250→ 1,351,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-20$8.06/sh+7,000$56,420→ 1,358,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-08-04$12.72/sh+10,200$129,744→ 1,465,193 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-15$7.99/sh+12,500$99,875→ 1,309,231 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-28$9.48/sh+5,000$47,400→ 1,391,768 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-07-31$11.86/sh+31,825$377,445→ 1,453,593 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-23$9.98/sh+15,000$149,700→ 1,386,768 total(indirect: See Remarks)
EW HEALTHCARE PARTNERS FUND 2-A, L.P.
10% OwnerOther
Transactions
- Purchase
Common Stock, par value $0.001 per share
2020-04-01$7.47/sh+15,000$112,050→ 1,169,231 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-08$8.37/sh+15,000$125,550→ 1,246,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-20$8.06/sh+7,000$56,420→ 1,358,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-07-28$12.48/sh+10,000$124,800→ 1,401,768 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-07-29$12.39/sh+12,600$156,114→ 1,414,368 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-07$8.20/sh+20,000$164,000→ 1,231,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-15$7.99/sh+12,500$99,875→ 1,309,231 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-03$8.01/sh+9,634$77,168→ 1,193,865 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-09$8.47/sh+25,000$211,750→ 1,271,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-13$7.96/sh+10,000$79,600→ 1,281,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-14$8.07/sh+15,000$121,050→ 1,296,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-16$8.00/sh+17,500$140,000→ 1,326,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-28$9.48/sh+5,000$47,400→ 1,391,768 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-07-31$11.86/sh+31,825$377,445→ 1,453,593 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-02$8.01/sh+15,000$120,150→ 1,184,231 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-06$8.10/sh+17,866$144,715→ 1,211,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-23$9.98/sh+15,000$149,700→ 1,386,768 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-17$8.25/sh+25,000$206,250→ 1,351,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-21$8.32/sh+3,037$25,268→ 1,361,768 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-22$9.14/sh+10,000$91,400→ 1,371,768 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-08-04$12.72/sh+10,200$129,744→ 1,465,193 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-08-11$12.95/sh+821$10,632→ 1,466,014 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-08-14$12.95/sh+9,179$118,868→ 1,475,193 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-07-30$12.22/sh+7,400$90,428→ 1,421,768 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2022-07-14$8.01/sh+5,000$40,050→ 3,610,709 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-08-03$11.86/sh+1,400$16,604→ 1,454,993 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-08-28$12.85/sh+100$1,285→ 1,475,293 total(indirect: See Remarks)
EW Healthcare Partners Fund 2 GP, L.P.
10% OwnerOther
Transactions
- Purchase
Common Stock, par value $0.001 per share
2020-04-16$8.00/sh+17,500$140,000→ 1,326,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-23$9.98/sh+15,000$149,700→ 1,386,768 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-07-28$12.48/sh+10,000$124,800→ 1,401,768 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-03$8.01/sh+9,634$77,168→ 1,193,865 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2022-07-14$8.01/sh+5,000$40,050→ 3,610,709 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-08$8.37/sh+15,000$125,550→ 1,246,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-15$7.99/sh+12,500$99,875→ 1,309,231 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-17$8.25/sh+25,000$206,250→ 1,351,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-28$9.48/sh+5,000$47,400→ 1,391,768 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-07-29$12.39/sh+12,600$156,114→ 1,414,368 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-08-04$12.72/sh+10,200$129,744→ 1,465,193 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-01$7.47/sh+15,000$112,050→ 1,169,231 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-13$7.96/sh+10,000$79,600→ 1,281,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-22$9.14/sh+10,000$91,400→ 1,371,768 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-21$8.32/sh+3,037$25,268→ 1,361,768 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-07-30$12.22/sh+7,400$90,428→ 1,421,768 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-08-03$11.86/sh+1,400$16,604→ 1,454,993 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-08-11$12.95/sh+821$10,632→ 1,466,014 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-08-14$12.95/sh+9,179$118,868→ 1,475,193 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-02$8.01/sh+15,000$120,150→ 1,184,231 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-06$8.10/sh+17,866$144,715→ 1,211,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-07$8.20/sh+20,000$164,000→ 1,231,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-07-31$11.86/sh+31,825$377,445→ 1,453,593 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-09$8.47/sh+25,000$211,750→ 1,271,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-14$8.07/sh+15,000$121,050→ 1,296,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-20$8.06/sh+7,000$56,420→ 1,358,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-08-28$12.85/sh+100$1,285→ 1,475,293 total(indirect: See Remarks)
EW Healthcare Partners Fund 2-UGP, LLC
10% OwnerOther
Transactions
- Purchase
Common Stock, par value $0.001 per share
2020-04-09$8.47/sh+25,000$211,750→ 1,271,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-07$8.20/sh+20,000$164,000→ 1,231,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-21$8.32/sh+3,037$25,268→ 1,361,768 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-23$9.98/sh+15,000$149,700→ 1,386,768 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-28$9.48/sh+5,000$47,400→ 1,391,768 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-06$8.10/sh+17,866$144,715→ 1,211,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-08$8.37/sh+15,000$125,550→ 1,246,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-01$7.47/sh+15,000$112,050→ 1,169,231 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-03$8.01/sh+9,634$77,168→ 1,193,865 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-14$8.07/sh+15,000$121,050→ 1,296,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-07-29$12.39/sh+12,600$156,114→ 1,414,368 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-02$8.01/sh+15,000$120,150→ 1,184,231 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-20$8.06/sh+7,000$56,420→ 1,358,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-13$7.96/sh+10,000$79,600→ 1,281,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-17$8.25/sh+25,000$206,250→ 1,351,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-22$9.14/sh+10,000$91,400→ 1,371,768 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-07-28$12.48/sh+10,000$124,800→ 1,401,768 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-08-04$12.72/sh+10,200$129,744→ 1,465,193 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-08-28$12.85/sh+100$1,285→ 1,475,293 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2022-07-14$8.01/sh+5,000$40,050→ 3,610,709 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-16$8.00/sh+17,500$140,000→ 1,326,731 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-07-30$12.22/sh+7,400$90,428→ 1,421,768 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-07-31$11.86/sh+31,825$377,445→ 1,453,593 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-04-15$7.99/sh+12,500$99,875→ 1,309,231 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-08-11$12.95/sh+821$10,632→ 1,466,014 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-08-14$12.95/sh+9,179$118,868→ 1,475,193 total(indirect: See Remarks) - Purchase
Common Stock, par value $0.001 per share
2020-08-03$11.86/sh+1,400$16,604→ 1,454,993 total(indirect: See Remarks)
Footnotes (43)
- [F1]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.38 to $7.56 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F10]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.36 to $8.38 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F11]The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 6,099 shares of the amount shown above and EW Fund 2-A purchased 8,901 shares of the amount shown above.
- [F12]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.35 to $8.58 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F13]The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 10,166 shares of the amount shown above and EW Fund 2-A purchased 14,834 shares of the amount shown above.
- [F14]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.93 to $8.00 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F15]The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 4,066 shares of the amount shown above and EW Fund 2-A purchased 5,934 shares of the amount shown above.
- [F16]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.05 to $8.09 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F17]The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 6,099 shares of the amount shown above and EW Fund 2-A purchased 8,901 shares of the amount shown above.
- [F18]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.97 to $8.00 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F19]The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 5,083 shares of the amount shown above and EW Fund 2-A purchased 7,417 shares of the amount shown above.
- [F2]The share total shown above is the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("EW Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("EW Fund 2-A," and together with EW Fund 2, the "EW Funds"), on the date set forth above. EW Fund 2 purchased 6,099 shares of the amount shown above and EW Fund 2-A purchased 8,901 shares of the amount shown above.
- [F20]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.99 to $8.02 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F21]The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 7,116 shares of the amount shown above and EW Fund 2-A purchased 10,384 shares of the amount shown above.
- [F22]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.18 to $8.29 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F23]The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 10,166 shares of the amount shown above and EW Fund 2-A purchased 14,834 shares of the amount shown above.
- [F24]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.03 to $8.14 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F25]The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 2,846 shares of the amount shown above and EW Fund 2-A purchased 4,154 shares of the amount shown above.
- [F26]The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 1,235 shares of the amount shown above and EW Fund 2-A purchased 1,802 shares of the amount shown above.
- [F27]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.08 to $9.19 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F28]The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 4,066 shares of the amount shown above and EW Fund 2-A purchased 5,934 shares of the amount shown above.
- [F29]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.95 to $9.99 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 6,099 shares of the amount shown above and EW Fund 2-A purchased 8,901 shares of the amount shown above.
- [F30]The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 6,099 shares of the amount shown above and EW Fund 2-A purchased 8,901 shares of the amount shown above.
- [F31]The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 2,033 shares of the amount shown above and EW Fund 2-A purchased 2,967 shares of the amount shown above.
- [F32]The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 4,066 shares of the amount shown above and EW Fund 2-A purchased 5,934 shares of the amount shown above.
- [F33]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.34 to $12.40 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F34]The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 5,124 shares of the amount shown above and EW Fund 2-A purchased 7,476 shares of the amount shown above.
- [F35]The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 3,009 shares of the amount shown above and EW Fund 2-A purchased 4,391 shares of the amount shown above.
- [F36]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.50 to $12.00 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F37]The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 12,941 shares of the amount shown above and EW Fund 2-A purchased 18,884 shares of the amount shown above.
- [F38]The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 569 shares of the amount shown above and EW Fund 2-A purchased 831 shares of the amount shown above.
- [F39]The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 4,148 shares of the amount shown above and EW Fund 2-A purchased 6,052 shares of the amount shown above.
- [F4]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.01 to $8.02 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F40]The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 334 shares of the amount shown above and EW Fund 2-A purchased 487 shares of the amount shown above.
- [F41]The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 3,732 shares of the amount shown above and EW Fund 2-A purchased 5,447 shares of the amount shown above.
- [F42]The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 41 shares of the amount shown above and EW Fund 2-A purchased 59 shares of the amount shown above.
- [F43]The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 1,965 shares of the amount shown above and EW Fund 2-A purchased 3,035 shares of the amount shown above.
- [F5]The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 3,917 shares of the amount shown above and EW Fund 2-A purchased 5,717 shares of the amount shown above.
- [F6]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.01 to $8.16 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F7]The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 7,265 shares of the amount shown above and EW Fund 2-A purchased 10,601 shares of the amount shown above.
- [F8]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.98 to $8.39 per share, inclusive. The reporting persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F9]The share total shown above is the aggregate amount of shares purchased by EW Fund 2 and EW Fund 2-A on the date set forth above. EW Fund 2 purchased 8,133 shares of the amount shown above and EW Fund 2-A purchased 11,867 shares of the amount shown above.
Documents
Issuer
TELA Bio, Inc.
CIK 0001561921
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001746779
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 4:10 PM ET
- Size
- 68.5 KB